Back to Search Start Over

Immunome to Present at Morgan Stanley 22nd Annual Global Healthcare Conference

Source :
Plus Company Updates. August 31, 2024
Publication Year :
2024

Abstract

BOTHELL: IMMUNOME, INC has issued the following news release: Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced that Clay Siegall, [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
Plus Company Updates
Publication Type :
News
Accession number :
edsgcl.806705452